STSS Overview

Strategic Collaboration: SHARPS Technology and The Tie have announced a strategic collaboration aimed at enhancing institutional participation in the Solana ecosystem.

Focus on Advancement: The partnership is designed to advance the integration of technology and institutional engagement within the Solana blockchain network.

Biotech Stocks Performance: Several small-cap biotech and healthcare companies saw notable gains in after-hours trading, driven by recent corporate updates and clinical milestones.

Inspira Technologies Update: Inspira Technologies Oxy B.H.N. Ltd. rose 5.88% following a recent agreement for a registered direct offering and a Standby Equity Purchase Agreement, despite no new news on the day.

MediciNova's Clinical Trial Success: MediciNova, Inc. advanced 4.83% after successfully completing patient enrollment in its Phase 2 OXTOX study, which evaluates MN-166 for preventing chemotherapy-induced peripheral neuropathy.

DiaMedica's FDA Meeting: DiaMedica Therapeutics Inc. gained 2.89% after a productive pre-IND meeting with the FDA regarding its study of DM199 in preeclampsia, with an additional non-clinical study requested.

Collaboration with Coinbase: Sharps Technology is expanding its Solana digital asset treasury strategy through a strategic partnership with Coinbase Global, utilizing Coinbase Prime's custody and OTC desk services.

Acquisition of SOL: The company has acquired over 2 million SOL, valued at over $400 million, with the cryptocurrency currently trading above $210.

Strategic Collaboration: Sharps Technology, Inc. has partnered with Coinbase to enhance its Solana digital asset treasury strategy, having acquired over 2 million SOL valued at over $400 million.

Utilization of Coinbase Services: The collaboration will leverage Coinbase's custody infrastructure and OTC desk products, aiming to support the global adoption of digital assets while ensuring secure and regulated service.

Stock Repurchase Program: Sharps Technology, Inc. has authorized a stock repurchase program to buy back up to $100 million of its outstanding common stock, aiming to enhance shareholder value and manage its capital structure.

Market Reaction: Following the announcement, Sharps Technology's stock rose by 8.41% in pre-market trading, reaching $7.35 on the Nasdaq.

Stock Repurchase Program: Sharps Technology (NASDAQ: STSS) has launched a stock repurchase program to buy back up to $100 million of its common stock, which is approximately 55.5% of its market cap of $180.35 million as of October 1, 2025.

Market Reaction: Following the announcement, shares of STSS increased by 1.92% in premarket trading on Thursday.